about
Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public HealthBacterial-Derived Polymer Poly-γ-Glutamic Acid (γ-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical ApplicationsNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophagesA biological perspective toward the interaction of theranostic nanoparticles with the bloodstream - what needs to be considered?Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.Cerium oxide nanoparticles promote neurogenesis and abrogate hypoxia-induced memory impairment through AMPK-PKC-CBP signaling cascade.Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infectionsNanomedicine strategies for drug delivery to the ear.Nanotechnology based anti-infectives to fight microbial intrusions.Exploiting microRNAs As Cancer Therapeutics.A recent trend of drug-nanoparticles in suspension for the application in drug delivery.Matrix Density Engineering of Hydrogel Nanoparticles with Simulation-Guided Synthesis for Tuning Drug Release and Cellular Uptake.Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Metallic nanoparticles for peripheral nerve regeneration: is it a feasible approach?Engineered cell migration to lesions linked to autoimmune disease.Applications of nanoparticle systems in drug delivery technology.Creation of a long-acting nanoformulated dolutegravir.Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
P2860
Q28384520-D80CB283-E27C-4D01-A168-73392F7C8387Q29248031-B17562E0-3A2F-41E0-9251-A423D5AAB63FQ30387307-EA80BEA6-737A-47A7-98AE-78E70B822CBCQ34632979-88FD4D22-B4D1-4816-BB0F-1C7BC7614130Q35067441-6C1A5288-3D41-4651-8312-F950E8F5F00AQ35088011-9A7F3842-A8C1-476E-BE18-ADDFFB48812AQ35979166-06BEACBF-9590-4BAD-AC4F-3EC412A97EC4Q36213685-877A71FF-3884-48E7-B1B1-67C71CCD7F81Q36757427-46E4FFB4-2899-4A77-AA68-E398D12E62BDQ37188867-54DEB63E-9E13-4BF3-AB12-EB6944D6D3D8Q38120319-C5F97B79-F384-4172-8940-D4093399E948Q38645320-EEDDA7C6-68CD-4CAC-B482-8318A642BBA9Q38764098-190CBB90-66D3-4363-9EC7-32573D10E9BBQ38985268-9CEF4E1F-CFD2-4AD3-984A-0C84CA4EF0CAQ41194560-C1A961D8-85FA-4EF3-88B9-2FF33D858F75Q41703512-4BDB812B-627C-426B-81CE-93B66E88C974Q42576760-915EF7B5-F09F-4362-BAAC-C5CAD2E816ABQ47240544-DC392440-1F48-4DD7-BB08-FB6A0BC2B49EQ49197456-242F6146-787B-4755-92B9-0C520C2DD214Q50051618-55668E19-84F7-4533-A66B-070EA051B524Q50278439-8DFE300D-A757-41BF-B4BC-5BFF3CF0BC29
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cell delivery of therapeutic nanoparticles
@ast
Cell delivery of therapeutic nanoparticles
@en
Cell delivery of therapeutic nanoparticles
@nl
type
label
Cell delivery of therapeutic nanoparticles
@ast
Cell delivery of therapeutic nanoparticles
@en
Cell delivery of therapeutic nanoparticles
@nl
prefLabel
Cell delivery of therapeutic nanoparticles
@ast
Cell delivery of therapeutic nanoparticles
@en
Cell delivery of therapeutic nanoparticles
@nl
P2093
P2860
P3181
P1476
Cell delivery of therapeutic nanoparticles
@en
P2093
Elena Batrakova
Howard E Gendelman
JoEllyn McMillan
P2860
P304
P3181
P356
10.1016/B978-0-12-416020-0.00014-0
P407
P577
2011-01-01T00:00:00Z